FDA approves cannabis-based treatment for cancer, AIDS-related weight loss – Cannabis News

Insys Therapeutics Inc. announced Tuesday, July 5, that the United States Food and Drug Administration (FDA) has approved the company’s drug Syndros, an orally administered liquid formulation of the synthetic cannabinoid dronabinol, according to a release.

Continue reading

WeedLife.com